CDT Equity (CDT) announced that, following its strategic review of the cryptocurrency and stablecoin market, engagement with third-party consultants and conversations with stakeholders, the Board has approved a cryptocurrency-based treasury reserve strategy to hold part of its current balance sheet, diversifying its capital management approach for the Company’s assets. The decision reflects the Company’s conviction that long-term exposure to digital assets presents both strategic and financial benefits for investors. As of September 2, 2025, the total number of shares of common stock outstanding was 3,382,025 and the total authorized shares of common stock are 250,000,000 shares. CDT continues to utilize its at-the-market facility with A.G.P./Alliance Global Partners as its primary source of funding.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CDT:
- CDT Equity identifies new biological target for AZD1656
- Conduit Pharmaceuticals Rebrands to CDT Equity Inc.
- Conduit Pharmaceuticals to change name to CDT Equity
- Conduit Pharmaceuticals files to sell 255K shares of common stock for holders
- Conduit Pharmaceuticals to explore cryptocurrency reserve strategy